Open Access

Erratum to: Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?

  • Jing Wen1,
  • Ying-Cheng Huang2,
  • Huan-Huan Xiu1,
  • Zhi-Ming Shan1 and
  • Kang-Qing Xu1Email author
Chinese Journal of Cancer201635:52

https://doi.org/10.1186/s40880-016-0116-0

Received: 8 June 2016

Accepted: 8 June 2016

Published: 14 June 2016

The original article was published in Chinese Journal of Cancer 2016 35:32

Erratum to: Chin J Cancer (2016) 35:32 DOI 10.1186/s40880-016-0094-2

After publication of the original article [1], the authors noticed an error in the body of text in the last paragraph of section ‘The structure and function of the STIM and ORAI protein families’. The sentence “The primary intracellular hysiologic functions of STIM and ORAI are straightforward” should read: “The primary intracellular physiological functions of STIM and ORAI are straightforward”.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University
(2)
Zhongshan School of Medicine, Sun Yat-sen University

Reference

  1. Wen J, Huang Y-C, Xiu H-H, Shan Z-M, Xu K-Q. Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy? Chin J Cancer. 2016;35:32. doi:10.1186/s40880-016-0094-2.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2016

Advertisement